|
🐜
|
Clinical validity of circulating tumour cells in patients with metastatic breast cancer: a pooled analysis of individual patient data.
43 auth.
F. Bidard,
D. Peeters,
T. Fehm,
F. Nolè,
R. Gisbert-Criado,
D. Mavroudis,
S. Grisanti,
D. Generali,
J. García-Saenz,
J. Stebbing,
C. Caldas,
P. Gazzaniga,
L. Manso,
R. Zamarchi,
Ángela Fernández de Lascoiti,
...
L. De Mattos-Arruda,
M. Ignatiadis,
R. Lebofsky,
S. V. van Laere,
F. Meier-Stiegen,
M. Sandri,
J. Vidal-Martínez,
E. Politaki,
F. Consoli,
A. Bottini,
E. Díaz-Rubio,
J. Krell,
S. Dawson,
C. Raimondi,
A. Rutten,
W. Janni,
E. Munzone,
V. Carañana,
S. Agelaki,
C. Almici,
L. Dirix,
E. Solomayer,
L. Zorzino,
H. Johannes,
J. Reis-Filho,
K. Pantel,
J. Pierga,
S. Michiels
|
9 |
2014 |
9
🐜
|
|
🐜
|
The clinical use of circulating tumor cells (CTCs) enumeration for staging of metastatic breast cancer (MBC): International expert consensus paper.
49 auth.
M. Cristofanilli,
J. Pierga,
J. Reuben,
A. Rademaker,
A. Davis,
D. Peeters,
T. Fehm,
F. Nolè,
R. Gisbert-Criado,
D. Mavroudis,
S. Grisanti,
M. Giuliano,
J. García-Saenz,
J. Stebbing,
C. Caldas,
...
P. Gazzaniga,
L. Manso,
R. Zamarchi,
Ángela Fernández de Lascoiti,
L. De Mattos-Arruda,
M. Ignatiadis,
L. Cabel,
S. V. van Laere,
F. Meier-Stiegen,
M. Sandri,
J. Vidal-Martínez,
E. Politaki,
F. Consoli,
D. Generali,
M. Cappelletti,
E. Díaz-Rubio,
J. Krell,
S. Dawson,
C. Raimondi,
A. Rutten,
W. Janni,
E. Munzone,
V. Carañana,
S. Agelaki,
C. Almici,
L. Dirix,
E. Solomayer,
L. Zorzino,
L. Darrigues,
J. Reis-Filho,
L. Gerratana,
S. Michiels,
F. Bidard,
K. Pantel
|
7 |
2019 |
7
🐜
|
|
🐜
|
MicroRNAs cooperatively inhibit a network of tumor suppressor genes to promote pancreatic tumor growth and progression.
21 auth.
A. Frampton,
L. Castellano,
T. Colombo,
E. Giovannetti,
J. Krell,
J. Jacob,
Loredana Pellegrino,
L. Roca-Alonso,
N. Funel,
T. Gall,
...
A. de Giorgio,
Filipa G Pinho,
V. Fulci,
D. Britton,
Raida Ahmad,
N. Habib,
R. Coombes,
V. Harding,
T. Knösel,
J. Stebbing,
L. Jiao
|
7 |
2014 |
7
🐜
|
|
🐜
|
Patient-derived xenografts for individualized care in advanced sarcoma
16 auth.
J. Stebbing,
K. Paz,
G. Schwartz,
L. Wexler,
R. Maki,
R. Pollock,
R. Morris,
Richard Cohen,
A. Shankar,
G. Blackman,
...
V. Harding,
David Vasquez,
J. Krell,
D. Ciznadija,
A. Katz,
D. Sidransky
|
7 |
2014 |
7
🐜
|
|
🐜
|
MicroRNAs Targeting Oncogenes Are Down-Regulated in Pancreatic Malignant Transformation from Benign Tumors
14 auth.
L. Jiao,
A. Frampton,
J. Jacob,
Loredana Pellegrino,
J. Krell,
G. Giamas,
N. Tsim,
P. Vlavianos,
Patrizia Cohen,
Raida Ahmad,
...
A. Keller,
N. Habib,
J. Stebbing,
L. Castellano
|
7 |
2012 |
7
🐜
|
|
🐜
|
Glypican-1 is enriched in circulating-exosomes in pancreatic cancer and correlates with tumor burden
12 auth.
A. Frampton,
Mireia Mato Prado,
E. López-Jiménez,
A. B. Fajardo-Puerta,
Z. Jawad,
P. Lawton,
...
E. Giovannetti,
N. Habib,
L. Castellano,
J. Stebbing,
J. Krell,
L. Jiao
|
6 |
2018 |
6
🐜
|
|
🐜
|
miR-23b regulates cytoskeletal remodeling, motility and metastasis by directly targeting multiple transcripts
16 auth.
Loredana Pellegrino,
J. Stebbing,
V. Braga,
A. Frampton,
J. Jacob,
L. Buluwela,
Long R. Jiao,
M. Periyasamy,
C. Madsen,
M. Caley,
...
S. Ottaviani,
L. Roca-Alonso,
M. El-Bahrawy,
R. Coombes,
J. Krell,
L. Castellano
|
6 |
2013 |
6
🐜
|
|
🐜
|
TGF-β induces miR-100 and miR-125b but blocks let-7a through LIN28B controlling PDAC progression
18 auth.
S. Ottaviani,
J. Stebbing,
A. Frampton,
Sladjana Zagorac,
J. Krell,
A. de Giorgio,
S. Trabulo,
Van T. M. Nguyen,
L. Magnani,
Hugang Feng,
...
E. Giovannetti,
N. Funel,
T. Gress,
L. Jiao,
Y. Lombardo,
N. Lemoine,
C. Heeschen,
L. Castellano
|
6 |
2018 |
6
🐜
|
|
🐜
|
The efficacy of axillary ultrasound in the detection of nodal metastasis in breast cancer.
7 auth.
Belinda Lee,
A. Lim,
J. Krell,
K. Satchithananda,
R. Coombes,
Jacqueline S. Lewis,
...
J. Stebbing
|
6 |
2013 |
6
🐜
|
|
🐜
|
Myocardial MiR-30 downregulation triggered by doxorubicin drives alterations in β-adrenergic signaling and enhances apoptosis
13 auth.
L. Roca-Alonso,
L. Castellano,
A. Mills,
Aleksandra Dabrowska,
M. Sikkel,
Loredana Pellegrino,
J. Jacob,
A. Frampton,
J. Krell,
R. Coombes,
...
Sian E. Harding,
Alexander R. Lyon,
J. Stebbing
|
6 |
2015 |
6
🐜
|
|
🐜
|
miR‐515‐5p controls cancer cell migration through MARK4 regulation
16 auth.
O. Pardo,
L. Castellano,
C. Munro,
Yili Hu,
F. Mauri,
J. Krell,
R. Lara,
Filipa G Pinho,
Thameenah Choudhury,
A. Frampton,
...
Loredana Pellegrino,
D. Pshezhetskiy,
Yulan Wang,
J. Waxman,
M. Seckl,
J. Stebbing
|
6 |
2016 |
6
🐜
|
